| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Samuel F Acuff, Justin C Stricklan. Divergence in cannabis and alcohol use disorder prevalence trends from 2002 to 2019. Drug and alcohol dependence. vol 266. 2024-12-10. PMID:39657438. |
despite increases in the availability, potency, and consumption of cannabis, epidemiological data suggest decreases in the prevalence of cannabis use disorder (cud) in some groups. |
2024-12-10 |
2024-12-13 |
Not clear |
| Sabrina Giguere, Mélissa Beaudoin, Laura Dellazizzo, Kingsada Phraxayavong, Stéphane Potvin, Alexandre Dumai. Avatar Intervention in Virtual Reality for Cannabis Use Disorder in Individuals With Severe Mental Disorders: Results From a 1-Year, Single-Arm Clinical Trial. JMIR mental health. vol 11. 2024-11-27. PMID:39602812. |
the dual diagnosis of cannabis use disorder (cud) and severe mental disorder (smd) results in clinically complex individuals. |
2024-11-27 |
2024-11-30 |
Not clear |
| James M Zech, David B Yaden, Grant M Jone. Associations between psychedelic use and cannabis use disorder in a nationally representative sample. Drug and alcohol dependence. vol 266. 2024-11-25. PMID:39586127. |
cannabis use disorder (cud) is an increasingly prevalent disorder affecting millions of americans each year. |
2024-11-25 |
2024-11-28 |
Not clear |
| Abay Woday Tadesse, Kim Betts, Berihun Assefa Dachew, Getinet Ayano, Rosa Alat. Maternal Cannabis Use Disorder and Neonatal Health Outcomes: A Data Linkage Study. BJOG : an international journal of obstetrics and gynaecology. 2024-11-25. PMID:39587322. |
we tested for the potential associations between maternal antenatal cannabis use disorders (cud) and neonatal health outcomes using large linked administrative data. |
2024-11-25 |
2024-11-28 |
Not clear |
| Najmeh Khosrovan Mehr, Fahimeh Fathali Lavasani, Alireza Noroozi, Hojjatollah Farahani, Banafsheh Gharrae. Effectiveness of the adolescent-community reinforcement approach for treating Cannabis use disorder in Iranian adolescents: A randomized controlled trial. Acta psychologica. vol 251. 2024-11-19. PMID:39561460. |
the adolescent community reinforcement approach (a-cra) is an evidence-based intervention for adolescents with cannabis use disorder (cud). |
2024-11-19 |
2024-11-23 |
human |
| Tanya Jain, Michelle Patriquin, Marsal Sanche. Associations between big five personality dimensions and lifetime use of cannabis. The American journal on addictions. 2024-11-18. PMID:39555836. |
with the rise in cannabis use over the last couple of decades and shifting social views around drug use, the characterization of potential predictors for the development of cannabis use disorder (cud) may be of high relevance for the implementation of preventive measures toward this condition. |
2024-11-18 |
2024-11-22 |
Not clear |
| Deborah S Hasin, Zachary L Mannes, Ofir Livne, David S Fink, Silvia S Martins, Malki Stohl, Mark Olfson, Magdalena Cerdá, Katherine M Keyes, Salomeh Keyhani, Caroline G Wisell, Julia M Bujno, Andrew Saxo. Cannabis Use and Cannabis Use Disorder Among U.S. Adults with Psychiatric Disorders: 2001-2002 and 2012-2013. Substance use & misuse. 2024-11-13. PMID:39533528. |
rates of cannabis use disorder (cud) have increased disproportionately among veterans administration (va) patients with psychiatric disorders compared to patients with no disorder. |
2024-11-13 |
2024-11-17 |
Not clear |
| Alannah Miranda, Breanna M Holloway, William Perry, Arpi Minassian, Michael McCarth. Co-morbid cannabis use disorder and chronotype are associated with mood symptom onset in people with bipolar disorder. Journal of psychiatric research. vol 180. 2024-11-08. PMID:39515185. |
comorbid cannabis use disorder (cud) is disproportionately high in people with bipolar disorder (bd) and has been associated with worsening of bd symptoms. |
2024-11-08 |
2024-11-16 |
human |
| Alannah Miranda, Breanna M Holloway, William Perry, Arpi Minassian, Michael McCarth. Co-morbid cannabis use disorder and chronotype are associated with mood symptom onset in people with bipolar disorder. Journal of psychiatric research. vol 180. 2024-11-08. PMID:39515185. |
to further disentangle these hypotheses, we aimed to investigate the relationship between chronotype, cannabis use disorder (cud) and bd mood symptoms. |
2024-11-08 |
2024-11-16 |
human |
| Jacob T Borodovsky, Deborah S Hasin, Melanie Wall, Cara A Struble, Mohammad I Habib, Ofir Livne, Jun Liu, Lynn Chen, Efrat Aharonovich, Alan J Budne. Quantity of delta-9-tetrahydrocannabinol consumption and cannabis use disorder among daily cannabis consumers. Addiction (Abingdon, England). 2024-11-06. PMID:39501796. |
amid escalating cannabis legalization and daily consumption in the united states (us), determining the risk of cannabis use disorder (cud) and relevant consequences among daily consumers has become a public health priority. |
2024-11-06 |
2024-11-08 |
Not clear |
| Jacob T Borodovsky, Deborah S Hasin, Melanie Wall, Cara A Struble, Mohammad I Habib, Ofir Livne, Jun Liu, Lynn Chen, Efrat Aharonovich, Alan J Budne. Quantity of delta-9-tetrahydrocannabinol consumption and cannabis use disorder among daily cannabis consumers. Addiction (Abingdon, England). 2024-11-06. PMID:39501796. |
this study characterized daily cannabis consumption using a new method for estimating milligrams of thc (mgthc), and examined the relationship between daily mgthc and cud severity in a large national sample of daily consumers. |
2024-11-06 |
2024-11-08 |
Not clear |
| Martin Ø Myhre, Eline Borger Rognli, Fredrik A Walby, Jørgen G Bramness, Lars Mehlu. The annual trend of suicide rates from 2010 to 2021 in patients with cannabis use disorder - a national registry study. Social psychiatry and psychiatric epidemiology. 2024-10-28. PMID:39466446. |
the temporal trend of suicide in patients with cannabis use disorder (cud) is important to investigate, considering the recent increases in thc concentration in cannabis products. |
2024-10-28 |
2024-10-31 |
Not clear |
| Gwen T Lapham, Jennifer F Bobb, Casey Luce, Malia M Oliver, Leah K Hamilton, Noorie Hyun, Kevin A Hallgren, Theresa E Matso. Prevalence of Cannabis Use Disorder Among Primary Care Patients with Varying Frequency of Past-Year Cannabis Use. Journal of general internal medicine. 2024-10-24. PMID:39446234. |
valid, single-item cannabis screens for the frequency of past-year use (sis-c) can identify patients at risk for cannabis use disorder (cud); however, the prevalence of cud for patients who report varying frequencies of use in the clinical setting remains unexplored. |
2024-10-24 |
2024-10-26 |
Not clear |
| Grace Williamson, Nora Trompeter, Dominic Murphy, Shaddy Saba, Eric R Pedersen, Jordan P Davis, Daniel Leightle. Using Passive and Active Data to Predict Post-Traumatic Stress Disorder Symptoms and Cannabis Use in Recently Discharged UK Veterans: A Protocol for the MAVERICK Feasibility Study. Mental health science. vol 2. issue 3. 2024-10-23. PMID:39440306. |
post-traumatic stress disorder (ptsd) and comorbid cannabis use disorder (cud) is a growing concern amongst uk veterans. |
2024-10-23 |
2024-10-25 |
Not clear |
| Lin Dong, Mengtong Xie, Weizhen Li, Min Zhang, Lijuan Yan, Qiong Yu, Yanchi Zhang, Xiaoyu L. Cannabis use disorder increases risk of large-artery atherosclerotic stroke and migraine with aura through mendelian randomization study. Scientific reports. vol 14. issue 1. 2024-10-16. PMID:39414896. |
observational studies have shown some association between cannabis use disorder (cud) and neurological disorders, but their causal relationship is unclear. |
2024-10-16 |
2024-10-19 |
Not clear |
| Bernard Le Foll, Victor M Tang, Sergio Rueda, Leanne V Trick, Isabelle Boilea. Cannabis use disorder: from neurobiology to treatment. The Journal of clinical investigation. vol 134. issue 20. 2024-10-15. PMID:39403927. |
a large number of people are using cannabis and some will develop cannabis use disorder (cud). |
2024-10-15 |
2024-10-17 |
Not clear |
| Suzan Maleki, Joshua Hendrikse, Karyn Richardson, Rebecca A Segrave, Sam Hughes, Edouard Kayayan, Stuart Oldham, Warda Syeda, James P Coxon, Karen Caeyenberghs, Juan F Domínguez D, Nadia Solowij, Dan I Lubman, Chao Suo, Murat Yüce. White matter alterations associated with chronic cannabis use disorder: a structural network and fixel-based analysis. Translational psychiatry. vol 14. issue 1. 2024-10-10. PMID:39389949. |
cannabis use disorder (cud) is associated with adverse mental health effects, as well as social and cognitive impairment. |
2024-10-10 |
2024-10-13 |
Not clear |
| Myra Alayoubi, Brittany A Henry, Catherine M Cahill, Ziva D Coope. Exploring Novel Pharmacotherapy Candidates for Cannabis Use Disorder: Uncovering Promising Agents on the Horizon by Mechanism of Action. Drugs. 2024-10-10. PMID:39388076. |
with rapid expansion of cannabis legalization worldwide, rates of cannabis use and cannabis use disorder (cud) are increasing; the need for safe and effective medications to treat cud is urgent. |
2024-10-10 |
2024-10-16 |
Not clear |
| Myra Alayoubi, Brittany A Henry, Catherine M Cahill, Ziva D Coope. Exploring Novel Pharmacotherapy Candidates for Cannabis Use Disorder: Uncovering Promising Agents on the Horizon by Mechanism of Action. Drugs. 2024-10-10. PMID:39388076. |
pharmacotherapies for cud are categorized based on compound targets (e.g., cannabinoid receptor 1 [cb1] agonists such as nabilone, serotonergic compounds such as bupropion, gabaergic compounds such as zolpidem) and outcomes are organized by predetermined withdrawal symptoms, cannabis craving, and cannabis relapse/use. |
2024-10-10 |
2024-10-16 |
Not clear |
| Emese Kroon, Lauren Kuhns, Janna Cousijn, Francesca Filbe. Cannabis cue-reactivity in cannabis use disorder: Diverging evidence in two distinct cannabis cultures. Journal of psychiatric research. vol 179. 2024-10-02. PMID:39357397. |
cannabis policies and attitudes play a role in the development and presentation of cannabis use disorder (cud), but it is unclear how these factors are related to biomarkers of addiction. |
2024-10-02 |
2024-10-05 |
Not clear |